Sitagliptin

Sitagliptin is a high-purity a-api supplied for industrial and specialty chemical applications. Contact our team for specifications, packaging options and lead times.

1. Treatment of Type 2 Diabetes

Sitagliptin is prescribed either as monotherapy or in combination with other antidiabetic drugs like metformin or sulfonylureas. It helps lower blood glucose levels by enhancing the body's natural ability to regulate insulin secretion in response to meals.

2. DPP-4 Inhibition Studies

Sitagliptin is widely used in research to study the role of DPP-4 enzymes, incretin hormones (GLP-1 and GIP), and the pancreatic β-cell response. It serves as a model compound in metabolic disease and endocrinology research.

3. Pharmaceutical Formulations

It is a key active pharmaceutical ingredient (API) in various commercial medications. Sitagliptin is often co-formulated with metformin (e.g., Janumet) to improve patient compliance and glycemic control.

4. Cardiovascular Risk Modulation (Under Research)

While primarily approved for glycemic control, sitagliptin has been studied for its cardiovascular safety profile in diabetic patients, contributing to a broader understanding of diabetes-related cardiovascular complications.

✅ Oral Administration

Sitagliptin丨CAS 486460-32-6 is available in convenient once-daily oral formulations, enhancing patient adherence compared to injectable treatments.

✅ Weight-Neutral and Low Hypoglycemia Risk

Unlike many other diabetes drugs, sitagliptin is weight-neutral and carries a low risk of hypoglycemia when used alone.

✅ Well-Tolerated and Safe

Extensive clinical data supports sitagliptin's long-term safety, tolerability, and efficacy in managing type 2 diabetes across diverse patient populations.

Previous

Octenidine Dihydrochloride丨CAS 70775-75-6

Next

Sumatriptan Succinate丨CAS 103628-48-4

A concise summary and suitability assessment for this product is available on request. Contact our team to discuss whether it fits your process and quality requirements.